DE3733478A1 - Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore - Google Patents

Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore

Info

Publication number
DE3733478A1
DE3733478A1 DE19873733478 DE3733478A DE3733478A1 DE 3733478 A1 DE3733478 A1 DE 3733478A1 DE 19873733478 DE19873733478 DE 19873733478 DE 3733478 A DE3733478 A DE 3733478A DE 3733478 A1 DE3733478 A1 DE 3733478A1
Authority
DE
Germany
Prior art keywords
treatment
composition according
pregnancy
methyl
hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19873733478
Other languages
German (de)
English (en)
Inventor
Walter Dr Elger
Sybille Dipl Biol Dr Beier
Marianne Dipl Biol Faehnrich
Beate Kosub
Krzysztof Dr Chwalisz
Syed Hamiduddin Dr Hasan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19873733478 priority Critical patent/DE3733478A1/de
Priority to JP63241208A priority patent/JP2656958B2/ja
Priority to JP63241207A priority patent/JP2620333B2/ja
Priority to AT88730222T priority patent/ATE106730T1/de
Priority to AU23321/88A priority patent/AU624082B2/en
Priority to DE3850026T priority patent/DE3850026D1/de
Priority to ZA887379A priority patent/ZA887379B/xx
Priority to CA000579022A priority patent/CA1330039C/en
Priority to CA000579023A priority patent/CA1329126C/en
Priority to PH37621A priority patent/PH26774A/en
Priority to IE295388A priority patent/IE65165B1/en
Priority to DK550188A priority patent/DK550188A/da
Priority to IE295488A priority patent/IE66335B1/en
Priority to AU23322/88A priority patent/AU616208B2/en
Priority to ES88730222T priority patent/ES2055745T3/es
Priority to EP88730221A priority patent/EP0310541B1/de
Priority to IL87885A priority patent/IL87885A/xx
Priority to EP19880730222 priority patent/EP0310542B1/de
Priority to ES88730221T priority patent/ES2053795T3/es
Priority to AT88730221T priority patent/ATE83149T1/de
Priority to DK550088A priority patent/DK550088A/da
Priority to ZA887378A priority patent/ZA887378B/xx
Priority to IL87886A priority patent/IL87886A/xx
Priority to DE8888730221T priority patent/DE3876582D1/de
Priority to US07/252,299 priority patent/US4888331A/en
Publication of DE3733478A1 publication Critical patent/DE3733478A1/de
Priority to GR920402867T priority patent/GR3007225T3/el
Priority to US08/195,046 priority patent/US5733902A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19873733478 1987-10-01 1987-10-01 Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore Withdrawn DE3733478A1 (de)

Priority Applications (27)

Application Number Priority Date Filing Date Title
DE19873733478 DE3733478A1 (de) 1987-10-01 1987-10-01 Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
JP63241208A JP2656958B2 (ja) 1987-10-01 1988-09-28 ホルモン依存性腫瘍治療剤
JP63241207A JP2620333B2 (ja) 1987-10-01 1988-09-28 抗ゲスターゲンおよび抗エストロゲン作用を有する化合物を含有する分娩誘発および妊娠中絶のためおよび子宮内膜症および月経困難症の治療のための薬剤
AU23322/88A AU616208B2 (en) 1987-10-01 1988-09-30 Compounds having antiprogestational and anti-estrogenic activities for induction of labor and for termination of pregnancy, as well as for the treatment of gynaecological disorders
IL87885A IL87885A (en) 1987-10-01 1988-09-30 Pharmaceutical compositions having antiprogestational and anti-estrogenic activities for the treatment of hormone- dependent tumors
DE3850026T DE3850026D1 (de) 1987-10-01 1988-09-30 Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren.
ZA887379A ZA887379B (en) 1987-10-01 1988-09-30 Compounds having antiprogestational and anti-estrogenic activities for induction of labor and for termination of pregnancy,as well as for the treatment of gynecological disorders
CA000579022A CA1330039C (en) 1987-10-01 1988-09-30 Compounds having anti-progestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
CA000579023A CA1329126C (en) 1987-10-01 1988-09-30 Compounds having anti-progestational and anti-estrogenic activities for induction of labor and for termination of pregnancy, as well as for the treatment of gynecological disorders
PH37621A PH26774A (en) 1987-10-01 1988-09-30 Compounds having an anti-progestational and anti-estrogenic activities for induction of labor and for termination of pregnancy
IE295388A IE65165B1 (en) 1987-10-01 1988-09-30 Compounds having antiprogestational and anti-estrogen activities
DK550188A DK550188A (da) 1987-10-01 1988-09-30 Antigestagen- og antioestrogenvirksomme forbindelser til behandling af hormonafhaengige tumorer
IE295488A IE66335B1 (en) 1987-10-01 1988-09-30 Compounds having antiprogestational and antiestrogenic activities for the treatment of hormone-dependent tumors
AT88730222T ATE106730T1 (de) 1987-10-01 1988-09-30 Antigestagen- und antiöstrogenwirksame verbindungen zur behandlung hormonabhängiger tumoren.
ES88730222T ES2055745T3 (es) 1987-10-01 1988-09-30 Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes.
EP88730221A EP0310541B1 (de) 1987-10-01 1988-09-30 Antigestagen- und antiöstrogenwirksame Verbindungen zur Geburtseinleitung und zum Schwangerschaftsabbruch sowie zur Behandlung gynäkologischer Störungen
AU23321/88A AU624082B2 (en) 1987-10-01 1988-09-30 Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
EP19880730222 EP0310542B1 (de) 1987-10-01 1988-09-30 Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
ES88730221T ES2053795T3 (es) 1987-10-01 1988-09-30 Compuestos con efecto antigestageno y antiestrogeno para la induccion de un embarazo y para la interrupcion de un embarazo, asi como para el tratamiento de trastornos ginecologicos.
AT88730221T ATE83149T1 (de) 1987-10-01 1988-09-30 Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen.
DK550088A DK550088A (da) 1987-10-01 1988-09-30 Antigestagen- og antioestrogenvirksomme forbindelser til foedselsindledning og svangerskabsforebyggelse samt til behandling af gynaekologiske forstyrrelser
ZA887378A ZA887378B (en) 1987-10-01 1988-09-30 Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
IL87886A IL87886A (en) 1987-10-01 1988-09-30 Pharmaceutical composition having antiprogestational and anti-estrogenic activities for gynecological use
DE8888730221T DE3876582D1 (de) 1987-10-01 1988-09-30 Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen.
US07/252,299 US4888331A (en) 1987-10-01 1988-10-03 Coadministration of antigestagen and antiestrogen for gynecological disorders, abortion and labor induction
GR920402867T GR3007225T3 (enExample) 1987-10-01 1993-03-05
US08/195,046 US5733902A (en) 1987-10-01 1994-02-14 Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873733478 DE3733478A1 (de) 1987-10-01 1987-10-01 Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore

Publications (1)

Publication Number Publication Date
DE3733478A1 true DE3733478A1 (de) 1989-04-13

Family

ID=6337559

Family Applications (3)

Application Number Title Priority Date Filing Date
DE19873733478 Withdrawn DE3733478A1 (de) 1987-10-01 1987-10-01 Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE3850026T Expired - Lifetime DE3850026D1 (de) 1987-10-01 1988-09-30 Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren.
DE8888730221T Expired - Lifetime DE3876582D1 (de) 1987-10-01 1988-09-30 Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE3850026T Expired - Lifetime DE3850026D1 (de) 1987-10-01 1988-09-30 Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren.
DE8888730221T Expired - Lifetime DE3876582D1 (de) 1987-10-01 1988-09-30 Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen.

Country Status (14)

Country Link
US (2) US4888331A (enExample)
EP (1) EP0310541B1 (enExample)
JP (2) JP2620333B2 (enExample)
AT (2) ATE106730T1 (enExample)
AU (2) AU616208B2 (enExample)
CA (2) CA1330039C (enExample)
DE (3) DE3733478A1 (enExample)
DK (2) DK550088A (enExample)
ES (2) ES2055745T3 (enExample)
GR (1) GR3007225T3 (enExample)
IE (2) IE65165B1 (enExample)
IL (2) IL87886A (enExample)
PH (1) PH26774A (enExample)
ZA (2) ZA887378B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19739916A1 (de) * 1997-09-11 1999-03-18 Hesch Rolf Dieter Prof Dr Med Mittel zur hormonalen Kontrazeption

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE4329344A1 (de) * 1993-08-27 1995-03-02 Schering Ag Progesteronantagonistisch- und antiöstrogen wirksame Verbindungen für die Behandlung des Leiomyomata uteri
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
GB9410533D0 (en) * 1994-05-26 1994-07-13 Lynxvale Ltd In situ hybridisation and immuno-Chemical localisation of a growth factor
DE4426601A1 (de) * 1994-07-27 1996-02-01 Schering Ag Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
DE19706061A1 (de) 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
US6653297B1 (en) * 1997-07-03 2003-11-25 Medical College Of Hampton Roads Control of selective estrogen receptor modulators
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6399593B1 (en) * 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
EP1173213A1 (en) * 1999-05-04 2002-01-23 American Home Products Corporation Compositions containing benzimidazolones and progestogens
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
SI1173210T1 (en) * 1999-05-04 2005-02-28 Wyeth Contraceptive compositions containing antiprogestinic and progestinic
US6380178B1 (en) * 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
ATE301129T1 (de) 1999-05-04 2005-08-15 Strakan Int Ltd Androgen glykoside und die androgenische aktivität davon
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
JP2004510994A (ja) * 2000-10-06 2004-04-08 バイオメディシンズ，インコーポレイティド エストロゲン−感受性疾病の処理のための組み合わせ治療
DE60115274T2 (de) * 2000-10-18 2006-07-27 Schering Ag Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
US6599921B2 (en) 2001-02-22 2003-07-29 Nanodesign, Inc. Non-steroidal estrogen receptor ligands
UY27301A1 (es) * 2001-05-25 2003-02-28 Schering Ag Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
US20030013694A1 (en) * 2001-05-25 2003-01-16 Jens Hoffmann Use and compositions of antiprogestins for treatment of prostate diseases
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
DE10159217A1 (de) * 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
EP1603563A4 (en) * 2003-02-28 2007-08-22 Morgan Lee R RESONANCE MODULATOR FOR DIAGNOSIS AND THERAPY
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
US8685950B2 (en) * 2004-10-04 2014-04-01 Wayne State University Use of aromatase inhibitors for treatment of ectopic pregnancy
WO2008019048A1 (en) * 2006-08-04 2008-02-14 Meditrina Pharmaceuticals Use of aromatase inhibitors for thining the endometrium or treating menorrhagia
US7694688B2 (en) 2007-01-05 2010-04-13 Applied Materials, Inc. Wet clean system design
WO2009075838A2 (en) * 2007-12-10 2009-06-18 Meditrina Pharmaceuticals, Inc. Treatment of menorrhagia with aromatase inhibitor
US20100087402A1 (en) * 2008-09-29 2010-04-08 Vivus, Inc. Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138504A2 (en) * 1983-10-12 1985-04-24 Imperial Chemical Industries Plc Steroid derivatives
US4670426A (en) * 1983-03-24 1987-06-02 Yeda Research And Development Co., Ltd. Interruption of fertility in mammals by post-coital pills

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
DE3323321A1 (de) * 1983-06-24 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
US4666885A (en) * 1985-02-08 1987-05-19 Fernand Labrie Combination therapy for treatment of female breast cancer
US4775660A (en) * 1984-08-02 1988-10-04 Fernand Labrie Treatment of breast cancer by combination therapy
IE58836B1 (en) * 1984-08-02 1993-11-17 Labrie Fernand Pharmaceutical composition for combination therapy of hormone dependent cancers
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
US4732904A (en) * 1984-12-24 1988-03-22 Morgan Lee R Antiestrogenic hydrazones
DE3533175A1 (de) * 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
FR2598083B1 (fr) * 1986-05-05 1989-12-29 Theramex Laboratoire Nouvelles compositions pharmaceutiques a action antiprogesteronique et leur procede d'obtention
DE3633244A1 (de) * 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670426A (en) * 1983-03-24 1987-06-02 Yeda Research And Development Co., Ltd. Interruption of fertility in mammals by post-coital pills
EP0138504A2 (en) * 1983-10-12 1985-04-24 Imperial Chemical Industries Plc Steroid derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19739916A1 (de) * 1997-09-11 1999-03-18 Hesch Rolf Dieter Prof Dr Med Mittel zur hormonalen Kontrazeption
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen

Also Published As

Publication number Publication date
AU616208B2 (en) 1991-10-24
AU2332288A (en) 1989-06-08
IE66335B1 (en) 1995-12-27
IE65165B1 (en) 1995-10-04
JP2656958B2 (ja) 1997-09-24
IE882954L (en) 1989-04-01
US5733902A (en) 1998-03-31
US4888331A (en) 1989-12-19
ZA887378B (en) 1989-05-30
ES2055745T3 (es) 1994-09-01
ATE106730T1 (de) 1994-06-15
JPH01106822A (ja) 1989-04-24
IL87885A0 (en) 1989-03-31
CA1329126C (en) 1994-05-03
AU624082B2 (en) 1992-06-04
IL87885A (en) 1993-06-10
GR3007225T3 (enExample) 1993-07-30
ATE83149T1 (de) 1992-12-15
IL87886A (en) 1993-06-10
DE3850026D1 (de) 1995-07-06
AU2332188A (en) 1989-04-20
CA1330039C (en) 1994-06-07
DK550188D0 (da) 1988-09-30
JPH01106823A (ja) 1989-04-24
DE3876582D1 (de) 1993-01-21
EP0310541A1 (de) 1989-04-05
EP0310541B1 (de) 1992-12-09
PH26774A (en) 1992-09-28
ES2053795T3 (es) 1994-08-01
DK550088A (da) 1989-04-02
DK550188A (da) 1989-04-02
DK550088D0 (da) 1988-09-30
JP2620333B2 (ja) 1997-06-11
IE882953L (en) 1989-04-01
IL87886A0 (en) 1989-03-31
ZA887379B (en) 1989-05-30

Similar Documents

Publication Publication Date Title
EP0310541B1 (de) Antigestagen- und antiöstrogenwirksame Verbindungen zur Geburtseinleitung und zum Schwangerschaftsabbruch sowie zur Behandlung gynäkologischer Störungen
DE19739916C2 (de) Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
DE60216630T2 (de) Verwendung von östrogen in kombination mit progestogen für die hormonsubstitutiionstherapie
DE69532894T2 (de) Verfahren zur empfängnisverhütung
DE4429398C2 (de) Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE3855606T2 (de) Verwendung von Melatonin zur Herstellung einer kontrazeptiven Zusammensetzung
DE3121152C2 (enExample)
EP0806952B1 (de) Verwendung von kompetitiven progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen
DE4429397C2 (de) Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE69729956T2 (de) Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
DE69327319T2 (de) Minimierung von mit progesteron verbundenen durchbruckblutungen
DE4426601A1 (de) Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri
WO1998035682A1 (de) Mittel zur hormonalen kontrazeption und/oder behandlung und/oder prophylaxe von tumoren der brustdrüsen mit drei hormonkomponente
DE19549264A1 (de) Verfahren und Kit zur Kontrazeption
EP0799042A1 (de) Progesteronantagonistisch- und antiöstrogen wirksame verbindungen zur gemeinsamen verwendung für die weibliche kontrazeption
EP0179421B1 (de) Antigestagene, Glukokortikoide und Prostaglandine zur Geburtseinleitung oder für den Schwangerschaftsabbruch
DE602004009288T2 (de) Verwendung einer kombination eines aromatasehemmers, eines progestins und eines oestrogens zur behandlung von endometriose
EP0310542B1 (de) Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
DE4329344A1 (de) Progesteronantagonistisch- und antiöstrogen wirksame Verbindungen für die Behandlung des Leiomyomata uteri
EP0296097B1 (de) Arzneimittel enthaltend Progesteronsynthesehemmer vom Typ des Trilostans oder Epostans und Antigestagene
DE3633244A1 (de) Antigestagene zur hemmung der uterinen prostaglandinsynthese
DE102019115343A1 (de) Vaginalring für die hormonelle Kontrazeption
EP0214924B1 (de) Oxytocin und Antigestagen zur Einleitung der Geburt
DE4216004A1 (de) Verwendung kompetitiver Progesteronantagonisten
EP0701445A1 (de) Mittel, enthaltend eine verbindung mit antiandrogener sowie eine verbindung mit kompetitiver, progesteronantagonistischer wirkung

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: SCHERING AG, 13353 BERLIN, DE

8110 Request for examination paragraph 44
8130 Withdrawal